| 前收市價 | 3.9000 |
| 開市 | 4.1300 |
| 買盤 | 3.6000 |
| 賣出價 | 5.3000 |
| 拍板 | 30.00 |
| 到期日 | 2024-08-16 |
| 今日波幅 | 4.0800 - 4.1600 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 3.41k |
ZacksWill BridgeBio Pharma (BBIO) Report Negative Q1 Earnings? What You Should Know
BridgeBio Pharma (BBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksBayer (BAYRY) Acquires BridgeBio's Cardiovascular Drug
Bayer (BAYRY) acquires exclusive marketing rights for cardiovascular drug acoramidis in Europe from BridgeBio for an upfront payment of $310 million.
Investor's Business DailyBridgeBio Dives After Inking A $310 Million Deal With Bayer For Its Lead Drug
Bayer snagged commercial rights to BridgeBio's lead asset, acoramidis, in Europe for $310 million. But BridgeBio stock tumbled Monday.
